DiaMedica Therapeutics (DMAC) Non Operating Income (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported Non Operating Income of $447000.0 for Q1 2026, up 0.9% on a YoY basis from $443000.0 in Q1 2025, and down 73.39% quarter-over-quarter from $1.7 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Non Operating Income (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Non Operating Income for 9 years, with the latest figure at $447000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 0.9% year-over-year to $447000.0; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 61.87% YoY), and the FY2025 full-year result was $1.7 million, down 26.82% from the prior year.
- Non Operating Income for Q1 2026 stood at $447000.0, down from $1.7 million in the prior quarter.
- The five-year high for Non Operating Income was $1.7 million in Q4 2025, with the low at -$21000.0 in Q3 2025.
- Historically, Non Operating Income has averaged $399647.1 across 5 years, with a median of $314000.0 in 2025.
- Annual changes were most pronounced in 2022 — Non Operating Income surged 3171.43% — and 2025, when it plunged 950.0%.
- DiaMedica Therapeutics' Non Operating Income stood at $229000.0 in 2022, then soared by 209.61% to $709000.0 in 2023, then retreated by 25.53% to $528000.0 in 2024, then soared by 218.18% to $1.7 million in 2025, then tumbled by 73.39% to $447000.0 in 2026.
- The last three Non Operating Income figures came in at $447000.0 (Q1 2026), $1.7 million (Q4 2025), and -$21000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 9.35 Mn |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | 447,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 447,000.00 |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | 314,000.00 |
| Mar 31, 2025 | 443,000.00 |
| Dec 31, 2024 | 528,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | 526,000.00 |
| Mar 31, 2024 | 597,000.00 |
| Dec 31, 2023 | 709,000.00 |
| Sep 30, 2023 | 693,000.00 |
| Jun 30, 2023 | 271,000.00 |
| Mar 31, 2023 | 256,000.00 |
| Dec 31, 2022 | 229,000.00 |
| Sep 30, 2022 | 76,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | -27,000.00 |
| Jun 30, 2021 | 98,000.00 |